Visiongain has published a new report entitled Pharma Contract Sales 2022-2032. It includes profiles of Pharma Contract Sales and Forecasts Market Segment by Type (Personal Promotion, Non-Personal Promotion, Co-Promotion) Market Segment by Personal Promotion, (Standard Field Force Roles, Sales Deployment, Vacancy Coverage, HCP Educational Programs, Key Account Management, Other Personal Promotion Services) Market Segment by Non-Personal Promotion, (Contact Center, Tele-detailing, Medical Call centres, Tele-sampling, Online Services) Market Segment by Therapeutics, (Cardiovascular Disease, Metabolic Disorders, Oncology, Alzheimer’s Disease, Diabetes, Other Therapeutics) Market Segment by Marketing Research and Consulting, (Product Commercialization, Territory Optimization & Alignment , Brand Management, Mature Product Line Support, Rest All CSO Services) plus COVID-19 Impact Analysis and Recovery Pattern Analysis (“V”-shaped, “W”-shaped, “U”-shaped, “L”-shaped), Profiles of Leading Companies, Region and Country.
The global pharma contract sales market was valued at US$5,303.0 million in 2021 and is projected to grow at a CAGR of 5.8% during the forecast period 2022-2032.
Pressure from the Pharmaceutical Industry Has Led To an Increase in Outsourcing
Pharmaceutical industries are under more pressure to cut costs as the market’s rivalry heats up. Pharmaceutical businesses have been compelled to restructure because of the enormous growth in fields like gene therapy and biologics. the need to withdraw from certain markets due to excessive labour costs or expensive drug markets. Lack of technical talent and skill shortages in the pharmaceutical sector high demand for pharmaceuticals from tech giants. The industry is anticipated to continue growing under the medium-term challenges and significant headroom provided by the current outsourcing penetration.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
How has COVID-19 had a significant negative impact on the Pharma Contract Sales Market?
Despite the fact that pharma contract sales are increasing as utilisation returns to normal, several intriguing patterns appeared as we combed through the data. As an illustration, the sector shown a remarkable capacity for sustaining therapeutic treatments for individuals with chronic diseases. The effects of lockdowns on these four areas are examined in more detail below, along with projections for when things will return to normal. It is comforting to observe that, based on overall sales, the majority of therapeutic areas only had a minimal disturbance during the epidemic. Sales should resume their typical growth trajectories as procedure backlogs continue to disappear. We also expect to see the sector capitalise on its success in providing patients with chronic diseases with care during a crisis.
How will this Report Benefit you?
Visiongain’s 357-page report provides 174 tables and 202 charts/graphs. Our new study is suitable for anyone requiring commercial, in-depth analyses for the global pharma contract sales market, along with detailed segment analysis in the market. Our new study will help you evaluate the overall global and regional market for Pharma Contract Sales. Get financial analysis of the overall market and different segments including personal promotion, non-personal promotion, co-promotion, therapeutics, and company size and market shares. We believe that there are strong opportunities in this fast-growing pharma contract sales market. See how to use the existing and upcoming opportunities in this market to gain revenue benefits in the near future. Moreover, the report will help you to improve your strategic decision-making, allowing you to frame growth strategies, reinforce the analysis of other market players, and maximise the productivity of the company.
Source: Globenewswire